Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS)

PURPOSE: Optimal management of breast ductal carcinoma in situ (DCIS) is controversial, and many patients are still overtreated. The local death of myoepithelial cells (MECs) is believed to be a pre-requisite to tumor invasion. We thus hypothesized that loss of CD10 expression, a MEC surface peptida...

Descripción completa

Detalles Bibliográficos
Autores principales: Toussaint, Jérôme, Durbecq, Virginie, Altintas, Sevilay, Doriath, Valérie, Rouas, Ghizlane, Paesmans, Marianne, Bedard, Philippe, Haibe-Kains, Benjamin, Tjalma, Wiebren A., Larsimont, Denis, Piccart, Martine, Sotiriou, Christos
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938371/
https://www.ncbi.nlm.nih.gov/pubmed/20856894
http://dx.doi.org/10.1371/journal.pone.0012100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938371/
https://www.ncbi.nlm.nih.gov/pubmed/20856894
http://dx.doi.org/10.1371/journal.pone.0012100

Ejemplares similares